The customer is always right? Subjective target symptoms and treatment preferences in patients with psychosis

European Archives of Psychiatry and Clinical Neuroscience

Volumn 267, Issue 4, 2017, Pages 335-339

  Moritz, Steffen ^a   Berna, Fabrice ^a   Jaeger, Susanne ^b   Westermann, Stefan ^c   Nagel, Matthias ^d,e  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF ULM   (Germany)

^c UNIVERSITY OF BERN   (Switzerland)

^d Asklepios Clinic   (Germany)

^e UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Psychosis; Schizophrenia; Treatment gap; Treatment preferences

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ANXIETY DISORDER; ART THERAPY; ARTICLE; COGNITIVE BEHAVIORAL THERAPY; COGNITIVE REMEDIATION THERAPY; COMPULSION; DANCE THERAPY; DEPRESSION; FAMILY THERAPY; FEMALE; HUMAN; LEISURE; LONELINESS; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE ASSESSMENT; MUSIC THERAPY; OBSESSION; OCCUPATIONAL THERAPY; PATIENT COMPLIANCE; PATIENT PREFERENCE; POSITIVE SYNDROME; PRIORITY JOURNAL; PSYCHOANALYSIS; PSYCHOEDUCATION; QUESTIONNAIRE; SCHIZOPHRENIA; SCHIZOPHRENIA SPECTRUM DISORDER; SOCIAL COMPETENCE; SPORT; E-MAIL; INFORMATION PROCESSING; METACOGNITION; MIDDLE AGED; PROCEDURES; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; PSYCHOSIS; PSYCHOTHERAPY; SELF CONCEPT; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

ADULT; ANTIPSYCHOTIC AGENTS; ART THERAPY; DATASETS AS TOPIC; ELECTRONIC MAIL; FEMALE; HUMANS; MALE; METACOGNITION; MIDDLE AGED; PATIENT PREFERENCE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTHERAPY; PSYCHOTIC DISORDERS; SELF CONCEPT; SURVEYS AND QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 84969919755     PISSN: 09401334     EISSN: 14338491     Source Type: Journal    
DOI: 10.1007/s00406-016-0694-5     Document Type: Article

References (38)

1. Way BB, Banks S (2001) Clinical factors related to admission and release decisions in psychiatric emergency services. Psychiatr Serv 52:214–218
2. Addington DE, Beck C, Wang J et al (2010) Predictors of admission in first-episode psychosis: developing a risk adjustment model for service comparisons. Psychiatr Serv 61:483–488. doi:10.1176/appi.ps.61.5.483
3. Kuhnigk O, Slawik L, Meyer J et al (2012) Valuation and attainment of treatment goals in schizophrenia: perspectives of patients, relatives, physicians, and payers. J Psychiatr Pract 18:321–328. doi:10.1097/01.pra.0000419816.75752.65
4. Peralta V, Cuesta MJ (2009) Characterization of affective domains within the nonaffective psychotic disorders. Schizophr Res 111:61–69. doi:10.1016/j.schres.2009.03.008
5. Cotton SM, Lambert M, Schimmelmann BG et al (2012) Depressive symptoms in first episode schizophrenia spectrum disorder. Schizophr Res 134:20–26. doi:10.1016/j.schres.2011.08.018
6. Moritz S, Cludius B, Hottenrott B et al (2015) Mindfulness and relaxation treatment reduce depressive symptoms in individuals with psychosis. Eur Psychiatry. doi:10.1016/j.eurpsy.2015.05.002
7. Van der Valk R, Van de Waerdt S, Meijer CJ et al (2013) Feasibility of mindfulness-based therapy in patients recovering from a first psychotic episode: a pilot study. Early Interv Psychiatry 7:64–70. doi:10.1111/j.1751-7893.2012.00356.x
8. Chadwick P (2014) Mindfulness for psychosis. Br J Psychiatry 204:333–334. doi:10.1192/bjp.bp.113.136044
9. Khoury B, Lecomte T, Fortin G et al (2013) Mindfulness-based therapy: a comprehensive meta-analysis. Clin Psychol Rev 33:763–771. doi:10.1016/j.cpr.2013.05.005
10. Hasson-Ohayon I, Kravetz S, Levy I, Roe D (2009) Metacognitive and interpersonal interventions for persons with severe mental illness: theory and practice. Isr J Psychiatry Relat Sci 46:141–148
11. White R, Gumley A, McTaggart J et al (2011) A feasibility study of Acceptance and Commitment Therapy for emotional dysfunction following psychosis. Behav Res Ther 49:901–907. doi:10.1016/j.brat.2011.09.003
12. Johnson DP, Penn DL, Fredrickson BL et al (2009) Loving-kindness meditation to enhance recovery from negative symptoms of schizophrenia. J Clin Psychol 65:499–509. doi:10.1002/jclp.20591
13. Moritz S, Rietschel L, Veckenstedt R, Bohn F, Schneider BC, Lincoln TM, Karow A (2015) The other side of “madness”: frequencies of positive and ambivalent attitudes towards prominent positive symptoms in psychosis. Psychosis 7:14–24. doi:10.1080/17522439.2013.865137
14. Moritz S, Favrod J, Andreou C et al (2013) Beyond the usual suspects: positive attitudes towards positive symptoms is associated with medication noncompliance in psychosis. Schizophr Bull 39:917–922. doi:10.1093/schbul/sbs005
15. Lasalvia A, Boggian I, Bonetto C et al (2012) Multiple perspectives on mental health outcome: needs for care and service satisfaction assessed by staff, patients and family members. Soc Psychiatry Psychiatr Epidemiol 47:1035–1045. doi:10.1007/s00127-011-0418-0
16. Hamann J, Mendel R, Cohen R et al (2009) Psychiatrists’ use of shared decision making in the treatment of schizophrenia: patient characteristics and decision topics. Psychiatr Serv 60:1107–1112. doi:10.1176/appi.ps.60.8.1107
17. Rosenheck R, Stroup S, Keefe RSE et al (2005) Measuring outcome priorities and preferences in people with schizophrenia. Br J Psychiatry 187:529–534. doi:10.1192/bjp.187.6.529
18. Byrne R, Davies L, Morrison AP (2010) Priorities and preferences for the outcomes of treatment of psychosis: a service user perspective. Psychosis 2:210–217. doi:10.1080/17522430903456913
19. Berry K, Haddock G (2008) The implementation of the NICE guidelines for schizophrenia: barriers to the implementation of psychological interventions and recommendations for the future. Psychol Psychother 81:419–436. doi:10.1348/147608308X329540
20. Bechdolf A, Klingberg S (2014) Psychotherapie bei schizophrenen Störungen: kein Evidenz-, sondern ein Implementierungsproblem [Psychotherapy of schizophrenia: Not a problem of evidence, but a problem of implementation]. Psychiatr Prax 41:8–10. doi:10.1055/s-0033-1359957
21. Puschner B, Vauth R, Jacobi F, Becker T (2006) Bedeutung von Psychotherapie in der Versorgung von Menschen mit schizophrenen Störungen in Deutschland: wie evidenzbasiert ist die Praxis? [Importance of psychotherapy in the health care of individuals with schizophrenia in Germany]. Nervenarzt 77:1301–1309. doi:10.1007/s00115-006-2102-2
22. Haddock G, Eisner E, Boone C et al (2014) An investigation of the implementation of NICE-recommended CBT interventions for people with schizophrenia. J Ment Health 23:162–165. doi:10.3109/09638237.2013.869571
23. Rummel-Kluge C, Pitschel-Walz G, Bäuml J, Kissling W (2006) Psychoeducation in schizophrenia–results of a survey of all psychiatric institutions in Germany, Austria, and Switzerland. Schizophr Bull 32:765–775. doi:10.1093/schbul/sbl006
24. Bundespsychotherapeutenkammer [Chamber of German Psychotherapists] (2014) BPtK-Studie zur stationären Versorgung psychisch kranker Menschen. Ergebnisse einer Befragung der in Krankenhäusern angestellten Psychotherapeuten [Study of the German chamber of psychotherapists about inpatient care in people with psychological disorders]. Bundespsychotherapeutenkammer, Berlin (Germany)
25. Prytys M, Garety PA, Jolley S et al (2011) Implementing the NICE guideline for schizophrenia recommendations for psychological therapies: a qualitative analysis of the attitudes of CMHT staff. Clin Psychol Psychother 18:48–59. doi:10.1002/cpp.691
26. Jaeger S, Wachter C, Steiner T (2014) Nicht-medikamentöse therapeutische Maßnahmen bei Schizophrenie—Was kennen Patienten? Was finden sie hilfreich? [Non-pharmacological therapeutic measures in schizophrenia—what do patients know? What do they judge as helpful?] DGPPN Kongress 2014
27. Stefanis NC, Hanssen M, Smirnis NK et al (2002) Evidence that three dimensions of psychosis have a distribution in the general population. Psychol Med 32:347–358. doi:10.1017/S0033291701005141
28. Moritz S, Van Quaquebeke N, Lincoln TM et al (2013) Can we trust the internet to measure psychotic symptoms? Schizophr Res Treat 2013:457010. doi:10.1155/2013/457010
29. Montag C, Haase L, Seidel D et al (2014) A pilot RCT of psychodynamic group art therapy for patients in acute psychotic episodes: feasibility, impact on symptoms and mentalising capacity. PLoS ONE 9:e112348. doi:10.1371/journal.pone.0112348
30. Deutsche Gesellschaft für Psychiatrie P und N (DGPPN) (eds) (2006) S3 Praxisleitlinien. Band 1 Behandlungsleitlinie Schizophrenie [S3 guidelines. Volume 1. Treatment guideline for schizophrenia]. Steinkopff, Darmstadt
31. Gosling SD, Vazire S, Srivastava S, John OP (2004) Should we trust web-based studies? A comparative analysis of six preconceptions about internet questionnaires. Am Psychol 59:93–104. doi:10.1037/0003-066X.59.2.93
32. Schneider F, Falkai P, Maier W (2012) Psychiatrie 2020. Perspektiven, Chancen und Herausforderungen [Psychiatry 2020. Perspectives, chance and challenges]. Springer, Heidelberg
33. Sun SX, Liu GG, Christensen DB, Fu AZ (2007) Review and analysis of hospitalization costs associated with antipsychotic nonadherence in the treatment of schizophrenia in the United States. Curr Med Res Opin 23:2305–2312. doi:10.1185/030079907X226050
34. Emsley R, Chiliza B, Asmal L, Harvey BH (2013) The nature of relapse in schizophrenia. BMC Psychiatry 13:50. doi:10.1186/1471-244X-13-50
35. Eiring Ø, Landmark BF, Aas E et al (2015) What matters to patients? A systematic review of preferences for medication-associated outcomes in mental disorders. BMJ Open 5:e007848. doi:10.1136/bmjopen-2015-007848
36. Naber D, Lambert M (2013) Should we listen and talk more to our patients? World Psychiatry 12:237–238. doi:10.1002/wps.20066
37. Suzuki T, Uchida H, Takeuchi H et al (2014) A review on schizophrenia and relapse–a quest for user-friendly psychopharmacotherapy. Hum Psychopharmacol 29:414–426. doi:10.1002/hup.2421
38. Westermann S, Cavelti M, Heibach E, Caspar F (2015) Motive-oriented therapeutic relationship building for patients diagnosed with schizophrenia. Front Psychol 6:1294. doi:10.3389/fpsyg.2015.01294